ga('require', 'linkid'); ga('set', 'anonymizeIp', true); ga('send', 'pageview');

Field Trials for Wound, Trauma, & Diabetic Care

  • Quickly & Accurately Determine Circulation in Extremities
  • Better than ABI to Measure Circulation Pre- and Post-Treatment 
  • Use in Trauma Care
  • Endothelial Dysfunction: Early Detection, Better Outcomes
  • Non-Invasive Biomarker Detection

Exhalix miniature sensors measure blood flow and gasses via cutaneous excretion. ​For faster results and more reliable evaluation at significantly lower cost than currently available, we are focused on developing miniature, affordable, real-time sensing technologies for point-of-care applications. We are committed to providing innovative solutions with state-of-the-art next generation technologies. We welcome teaming with research partners to address health-related detection, diagnostics, and monitoring challenges.

Join Our Field Trials

We are currently engaged in research, teaming with other investigators, to evaluate uses of hydrogen sulfide measurements, breath or through skin, for therapeutic or diagnostic monitoring.

Transdermal Gasotransmitter Sensor (TAGS™)

​Our team at Exhalix is developing a non-invasive point-of-care diagnostic technique for detection of endothelial dysfunction in the high risk diabetic population.